Yvonne Paterson, Ph.D.
Dr. Yvonne Paterson is a Professor in the Department of Microbiology, Associate Dean for Postdoctoral Research Training and Director of Biomedical Post-doctoral Programs at the University of Pennsylvania School of Medicine. She is also a member of the University of Pennsylvania Cancer Center and the Center for AIDS Research. Dr. Paterson completed her B.Sc. and M.Sc. in Biochemistry at the University of Manchester, England. Additionally, she received her BA in Mathematics and Philosophy from the Australian National University and completed her Ph.D. in Biochemistry at Melbourne University in 1979. She continued her training as a Postdoctoral Fellow at Cornell University from 1979-82 and then became an Assistant Professor in the Department of Immunology at the Scripps Research Institute. She joined the faculty of the Microbiology Department at the University of Pennsylvania in 1988 and was promoted to full Professor in 1993. Dr. Paterson has been an invited speaker at national and international health field conferences and leading academic institutions. She has served on many federal advisory boards such as the NIH expert panel to review primate centers, the Office of AIDS Research Planning Fiscal Workshop and the Allergy and Immunology NIH Study Section. She has been Section Editor of the Journal of Immunology . She has written over 120 publications (including a recently published book) in Immunology most recently in the areas of HIV Aids and Cancer research. Her instruction and mentorship has trained over 40 post-doctoral and doctoral students in the fields of Biochemistry and Immunology, many of whom are research leaders in academia and industry. Her research interests are broad but for the past ten years her laboratory has been focused on developing novel approaches for prophylactic vaccines against infectious disease and immunotherapeutic approaches to cancer. The approach of the laboratory is based on a long-standing interest in the properties of proteins that render them immunogenic and how such immunogenicity may be modulated in vivo.
Back to Scientific Advisory Board Home